Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy

Checkpoint-based immunotherapies, such as programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) inhibitors, have shown promising clinical outcomes in many types of cancers. Unfortunately, the response rate of immune checkpoint inhibitors is low. It is very important to discover novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huixian, Zhao, Wencheng, Li, Xingya, He, Yayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232957/
https://www.ncbi.nlm.nih.gov/pubmed/34188488
http://dx.doi.org/10.2147/OTT.S315998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232957/
https://www.ncbi.nlm.nih.gov/pubmed/34188488
http://dx.doi.org/10.2147/OTT.S315998

Ejemplares similares